BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Oncolab Incorporated

The AMAS Test measures serum levels of AMA, an antibody found to be elevated in most patients with a wide range of active non-terminal malignancies.


Contact Details:
36 The Fenway
Boston
MA
02215
United States of America
Tel:617 536 0850
Fax:617 536 0657
Email:info@amascancertest.com
WWW:

www.amascancertest.com/
Loading...

Recent Publications by Oncolab Incorporated:

Biological markers and DNA flow cytometric analysis in radically resected patients with non-small cell lung cancer. A study of the Perugia Multidisciplinary Team for Thoracic Tumors.
AIMS AND BACKGROUND: The aim of this study was to evaluate the...		30th August, 2008
Medical Oncology, Azienda Tumori. 2008 May-Jun;94(3):398-405.
Evaluation of serum HER2 extracellular domain in early breast cancer patients: correlation with clinicopathological parameters and survival.
BACKGROUND: We explored the correlation between serum human epidermal...		25th June, 2008
Medical Oncology Division, Azienda Ospedaliera of Perugia, Perugia, Italy. Ann Oncol. 2008 May;19(5):883-90. Epub 2008 Jan 10.
DOI Direct Link
Plasma DNA, microsatellite alterations, and p53 tumor mutations are associated with disease-free survival in radically resected non-small cell lung cancer patients: a study of the perugia multidisciplinary team for thoracic oncology.
INTRODUCTION: This prospective study examined association between...		28th May, 2008
Medical Oncology Division, Azienda Ospedale Perugia, Via Brunamonti 51, J Thorac Oncol. 2008 Apr;3(4):365-73.
DOI Direct Link
Pathogenic validation of unique germline intronic variants of RB1 in retinoblastoma patients using minigenes.
Precise identification of the pathogenic character of germline mutations...		29th January, 2008
OncoLab, Departamento de Biologia Molecular y Celular del Cancer, Hum Mutat. 2007 Dec;28(12):1245.
DOI Direct Link
[Molecular diagnosis of retinoblastoma: molecular epidemiology and genetic counseling]
BACKGROUND AND OBJECTIVE: Retinoblastoma, a prototype of hereditary...		5th August, 2006
OncoLab, Departamento de Biologia Molecular y Celular del Cancer, Med Clin (Barc). 2006 Mar 25;126(11):401-5.

→View more Oncolab Incorporated research publications.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 348 times since April 2007, the link to the organisation's website has been followed 83 times

Recent Search Terms used to find this page: t | OncoLab Departamento de Biolog a Molecular y Celular del C ncer | oncolab | oncolab | ONCOLAB | oncolab instituto | oncolab instituto | oncolab | Oncolab | amascancertest | .

Search for more companies in Boston

Search for more companies in MA



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Oncolab Incorporated
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.